Crystal Pharmatech Small Molecule CMC Strategy at PBSS 2026 San Francisco

DMPK & Bioanalytical Technologies and Case Studies: Small Molecules, Peptides, and Nucleotides

Join Crystal Pharmatech at PBSS on April 17, 2026, in the San Francisco Bay Area. This technical workshop focuses on small molecule preclinical development and IND filing—the ideal setting for strategic CMC discussions.

What you will take away from Crystal Pharmatech? 

Our experts will lead discussions around early CMC strategy, focusing on: 

• Solid State Research: Identifying the best crystal form early

• Pre-formulation: Assessing developability to de-risk your molecule.

• Formulation Development: Bridging the gap from bench to clinic. 

We look forward to connecting on how integrating these phases early can reduce uncertainty, conserve precious API, and support a more confident progression to clinical trials.